Cargando…
Clinical effects of tranexamic acid on bleeding tendency due to fibrinolytic activation of AL amyloidosis
We report a case where tranexamic acid, which is an antifibrinolytic agent, was used to effectively treat bleeding tendency in a patient with immunoglobulin light chain (AL) amyloidosis. A male patient in his 80s without a history of bleeding disorders was admitted to our hospital for the examinatio...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533652/ https://www.ncbi.nlm.nih.gov/pubmed/37751987 http://dx.doi.org/10.1136/bcr-2022-254483 |